Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors

Proteasome inhibitors (PIs) have markedly improved response rates as well as the survival of multiple myeloma (MM) patients over the past decade and have become an important foundation in the treatment of MM patients. Unfortunately, the majority of patients either relapses or becomes refractory to p...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Control Release
Päätekijät: Hu, Hangting, Petrosyan, Armen, Osna, Natalia A., Liu, Tong, Olou, Appolinaire A., Alakhova, Daria Y., Singh, Pankaj K., Kabanov, Alexander V., Faber, Edward A., Bronich, Tatiana K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822276/
https://ncbi.nlm.nih.gov/pubmed/31121280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.05.026
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia